Acute infections commonly cause a range of unpleasant urinary diseases and symptoms including cystitis. Chronic infections also cause diseases such as interstitial cystitis, kidney stones, and hematuria.
Sometimes a urinary symptom masks as an infection and is actually immunopathology. Adjusting the Marshall Protocol (MP) medications is the best way to manage symptoms of immunopathology.
While urine within the urinary tract has been traditionally regarded as “sterile”, this assumption relies on culture-based methods, which capture a small fraction of microbial richness. A 2011 pyrosequencing study looked at 16S rDNA amplicons of eight culture-negative healthy female urine specimens.1 The study found significant diversity, with the predominant genera detected being Lactobacillus, Prevotella and Gardnerella. Notably, a significant amount of sequences belonging to bacteria with a known pathogenic potential was observed.
The medical term for bladder or urinary tract infection (UTI) is cystitis, which literally means inflammation of the urinary bladder. A UTI is often caused by an acute bacterial infection. UTIs can occur in any part of the urinary tract including the kidneys, ureters, urethra and bladder. UTIs are more common in women because a woman's shorter urethra provides easier access for bacteria, but men are also susceptible.
Symptoms of a UTI include:
A UTI is diagnosed with a urinalysis to assess the amount of bacteria in the urine. Although urine contains a variety of fluids. salts, and waste products, it normally does not have bacteria in it. Sometimes a culture of the bacteria is done to determine the appropriate antibiotic. Until one's doctor does a culture and sensitivity, any antibiotic a patient is given for a urinary tract infection is an educated guess.
Irritation in the urinary tract is not related to the alkalinity or acidity of urine.
If a urinalysis is positive for bacteria and one's doctors wants to use an antibiotic other than minocycline, ask him or her to consider a fluoroquinolone, which will not interfere with immunopathology.
Other strategies for managing a UTI include:
Note that excessive urination, known as polyuria, may be due to subclinical kidney inflammation.
Kidney stones, also called renal calculi, are crystal aggregations of dissolved minerals in urine. Kidney stones typically form inside the kidneys or bladder and can primarily consist of a variety of substances including calcium oxalate, uric acid, and struvite (magnesium, ammonium and phosphate). According to the Marshall Pathogenesis, there are two factors that seem to play a role in kidney stone formation: elevated levels of 1,25-D and the presence of bacteria.
Patients on the Marshall Protocol (MP) are somewhat less likely to get kidney stones, especially in later stages of the treatment, due to the restoration of proper vitamin D metabolism. Those patients who do develop kidney stones since starting the MP, should know they are a result of months or years of development and not due to the effects of the MP. The MP should prevent recurrence.
Interstitial cystitis/painful bladder syndrome is a urinary bladder disease of unknown cause characterized by pain associated with urination (dysuria), urinary frequency (as often as every 10 minutes), urgency, and pressure in the bladder and/or pelvis.
My interstitial cystitis has improved greatly on the MP. Before the MP, I went for eight years in need of five medications everyday and no relief. I did not respond to Ciprofloxacin and showed no bacteria according to the urologist. I wanted to kill myself as it was so bad. After eight months on MP, I do not need any more meds, and the interstitial cystitis is doable. Before the MP, there were no antibiotics to treat IC as they considered it an inflammatory disease.
Bacterial vaginosis is a common syndrome associated with numerous adverse health outcomes in women. According to a 2012 study using broad-range PCR , the community of vaginal bacteria detected in subjects with BV was much more taxon rich and diverse than in subjects without BV.4 Actinobacteria and Bacteroidetes were strongly associated with BV.
Hematuria, or haematuria, is the presence of red blood cells (erythrocytes) in the urine. It can be a sign that there is a kidney stone or a tumor in the urinary tract (kidneys, ureters, urinary bladder, prostate, and urethra), ranging from trivial to lethal. If white blood cells are found in addition to red blood cells, then it is a signal of urinary tract infection.
I had haematuria also and because I was hypercalcaemic, had calcium oxalate kidney stones…. Since going on the MP, I don't have anymore stones forming or passing and my haematuria has gone.
Simom Elrahi, MarshallProtocol.com
Antibiotics Can Help Improve Overactive Bladder Print This Email this
By Fran Lowry
NEW YORK (Reuters Health) Sep 06 - Patients with overactive bladder (OAB) symptoms and pyuria benefited from six to nine months of antibiotics, researchers reported in Glasgow, Scotland last week at the 41st annual meeting of the International Continence Society.
“There is a growing body of evidence that identifies a group of patients who, despite presenting with negative routine urinalyses, appear to have an infection or an inflammatory process at the heart of the cause of their overactive bladder symptoms,” Dr. Kiren Gill, of University College London, UK, told Reuters Health. “We think about half of patients with OAB may have bacteria in their urine.”
Dr. Gill and his team conducted an observational study of 440 patients (380 females and 60 males; mean age, 54) with OAB between 2003- 2010.
They divided patients into three groups. Group 1, with 147 patients, had pyuria and were treated from the start with antibiotics, primarily nitrofurantoin (100 mg bid) or cephalexin (500 mg bid) for six to nine months, in addition to anti-muscarinics and bladder retraining.
Group 2, with 212 patients, had no pyuria and received anti-muscarinics and bladder retraining.
Group 3, with 81 patients, did not manifest signs of pyuria until a follow-up exam, at which point they received antibiotics.
When they entered the study, 75% of the patients in group 1, 88% in group 2, and 85% in group 3 had negative mid-stream urine cultures, said Dr. Gill.
All three treatment groups had significant improvement in OAB symptoms of urgency, 24 hour frequency episodes and incontinence, Dr. Gill reported.
Group 3 patients, who received antibiotics later, took significantly longer to recover (198 - 321 days) than patients who received antibiotics from the start (Group 1, 165 to 229 days; p < 0.001). Group 2 patients, who had no pyuria, recovered the fastest (138 to 180 days).
Dr. Gill said the data provide strong justification for a large-scale, randomized placebo-controlled trial of antibiotics in patients with OAB pyuria but negative urine culture.
The danger of antibiotic resistance is low, he believes.
“We have looked at over 65,000 culture samples and have not found any increased risk of antibiotic resistance,” he said. “A Darwinian understanding of the underlying pathophysiology would lead us to expect very low levels of antibiotic resistance. For resistance to occur, bacterial replication is required to allow for variation and the influence of selection pressure. But in OAB, there is evidence that the bacteria are relatively dormant, and replication is low, so the chances of developing resistance in the offending pathogens are very low and our data confirm this.”